Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEDIPASVIR vs LENACAPAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEDIPASVIR vs LENACAPAVIR: Safety Overview

Metric LEDIPASVIR LENACAPAVIR
Total FAERS Reports 516 502
Deaths Reported 304 32
Death Rate 58.9% 6.4%
Hospitalizations 34 42
Average Patient Age 58.5 yrs 50.0 yrs
% Female Patients 29.5% 24.7%
FDA Approval Date N/A Dec 22, 2022
Manufacturer Gilead Sciences, Inc Gilead Sciences, Inc.
Route ORAL ORAL
Marketing Status N/A Prescription